Literature DB >> 16806218

Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.

Yuan-Yuan Wang1, Jun Luo, Ming-Wei Zhu, Lan-Nv Liu, Xu Ma.   

Abstract

OBJECTIVES: To compare the performance of double screening (measuring maternal serum levels of alpha-fetoprotein [AFP] and total beta-human chorionic gonadotrophin [hCG] as markers for Down syndrome) with that of triple screening (also measuring levels of unconjugated estriol [uE3]) in the second trimester of pregnancy, and to compare ethnic variance between Chinese and Caucasian populations.
METHODS: The study investigated 15096 normal singleton pregnancies and 24 pregnancies affected with Down syndrome. Frequency distributions of AFP, hCG, and uE3 levels were analyzed. Likelihood ratios (LRs) were calculated using the multiple of median value (MoM) of AFP, hCG, and uE3 as variables. After multiplying maternal age risk by the LR values for the markers used in double and triple screening, the specific risks obtained with double and triple screening were estimated. The detection rate (DR) and false-positive rate (FPR) were calculated at different cut-off points. The serum markers' levels were also compared with those of Caucasian women.
RESULTS: The median MoM value of hCG was higher in women with affected pregnancies (1.40) than those with unaffected pregnancies (1.00). However, the median MoMs of AFP and uE3 (0.79 and 0.68) were lower in affected than in unaffected pregnancies. At a FPR of 5%, the detection rates reached with double and triple screening were 50% and 66.7%, respectively. Ratios of the 3 serum markers' medians to those in a study with Caucasian women were 1.06 (range=1.04-1.09) for AFP, 1.14 (range=1.10-1.17) for hCG, and 1.28 (range=1.23-1.41) for uE3 for the relevant gestational weeks.
CONCLUSION: Triple screening performed better than double screening in the second trimester. Ethnic variance should be taken into account in Down syndrome screening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806218     DOI: 10.1016/j.ijgo.2006.04.030

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  10 in total

1.  Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.

Authors:  Savitree Pranpanus; Ounjai Kor-Anantakul; Thitima Suntharasaj; Chitkasaem Suwanrath; Tharangrut Hanprasertpong; Ninlapa Pruksanusak; Chusana Petpichetchian; Manaphat Suksai; Natthicha Chainarong; Rapphon Sawaddisan
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  A population-based study of prevalence of Down syndrome in Southern Thailand.

Authors:  Somchit Jaruratanasirikul; Ounjai Kor-Anantakul; Montira Chowvichian; Wannee Limpitikul; Pathikan Dissaneevate; Nitthakarn Intharasangkanawin; Atchara Sattapanyo; Sermsri Pathompanitrat; H Sriplung
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

3.  Combined detection of α-fetoprotein and free β-human chorionic gonadotropin in screening for trisomy 21 and management of cases in the moderate risk value range.

Authors:  Yahong Li; Xiaojuan Zhang; Yun Sun; Dongyang Hong; Yanyun Wang; Zhengfeng Xu; Tao Jiang
Journal:  Mol Clin Oncol       Date:  2017-07-31

4.  Korean-specific parameter models for calculating the risk of Down syndrome in the second trimester of pregnancy.

Authors:  Ji Young Kwon; In Yang Park; Yong Gue Park; Young Lee; Guisera Lee; Jong Chul Shin
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

5.  Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.

Authors:  Bin Yu; Bin Zhang; Ye Shi; Shi-He Shao; Qiu-Wei Wang; Rui-Ping Huang; Yu-Qi Yang
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

6.  Triple test screening for Down syndrome: an Egyptian-tailored study.

Authors:  Hazem S Abou-Youssef; Manal M Kamal; Dina A Mehaney
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

7.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

8.  Prenatal Diagnostic Testing Following High-Risk Result from Serological Screening: Which Shall We Select?

Authors:  Jing Wang; Xin-Xin Tang; Qin Zhou; Shuting Yang; Ye Shi; Bin Yu; Bin Zhang; Lei-Lei Wang
Journal:  Int J Womens Health       Date:  2021-09-22

Review 9.  Two kinds of common prenatal screening tests for Down's syndrome: a systematic review and meta-analysis.

Authors:  Yuan Yao; Yang Liao; Mei Han; Sheng-Lan Li; Juan Luo; Bo Zhang
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

10.  Analysis of Down syndrome failed to be diagnosed after prenatal screening: A multicenter study.

Authors:  Tao Jiang; Jie Ding; Xiao-Qing Zhang; Xiao-Juan Zhang; Bin Zhang; Ting Wang; Bin Yu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.